africanews.com·3 min read·medium
First person vaccinated during trial of new Ebola jab
A
AfricaNews
✦AI Summary
Oxford University has begun human clinical trials for a new vaccine targeting the Bundibugyo strain of Ebola. The vaccine, developed in just eight weeks, is being tested on healthy volunteers to assess safety and efficacy.
A volunteer was injected on Friday with the first dose of a rapidly developed vaccine targeting the Bundibugyo strain of Ebola driving a deadly outbreak in the Democratic Republic of Congo, Oxford University said.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in